Evidence map›Paper›PMID 25625589›Full record

ArticleEndocrinology2015

Disruption of insulin signaling in Myf5-expressing progenitors leads to marked paucity of brown fat but normal muscle development.

Matthew D Lynes, Tim J Schulz, Andrew J Pan, Yu-Hua Tseng

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Adipose METTL14-Elicited NAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Matthew D LynesSection on Integrative Physiology and Metabolism (M.D.L., Y.-H.T.), Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts 02215; Department of Adipocyte Development (T.J.S.), German Institute of Human Nutrition, Potsdam-Rehbrücke, Germany 14558; Stem Cell and Regenerative Biology Department (A.J.P.), Harvard University, Cambridge, Massachusetts; and Harvard Stem Cell Institute (Y.-H.T.), Harvard University, Cambridge, Massachusetts 02138.
Tim J Schulz
Andrew J Pan
Yu-Hua Tseng
Harvard University · USGerman Institute of Human Nutrition · DEJoslin Diabetes Center · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
TRAINING IN DIABETES AND METABOLISMT32DK007260 · NIDDK · JOSLIN DIABETES CENTER · PI LAURIE J GOODYEAR · 1986 to 2026
$13.6M
Role of BMPs in Adipogenesis, Mitochondrial Function and Energy MetabolismR01DK077097 · NIDDK · JOSLIN DIABETES CENTER · PI TSENG, YU-HUA · 2007 to 2019
$5.6M
Telomerase as a Marker of Brown and White Adipose Tissue Stem CellsF32DK102320 · NIDDK · JOSLIN DIABETES CENTER · PI LYNES, MATTHEW D · 2014 to 2014
$53k
NIDDK NIH HHS F32 DK102320NIDDK NIH HHS F32DK102320NIDDK NIH HHS P30 DK036836NIDDK NIH HHS P30DK036836NIDDK NIH HHS R01 DK077097NIDDK NIH HHS R01DK077097NIDDK NIH HHS T32 DK007260NIDDK NIH HHS T32DK007260
6 · The paper itself

Abstract

Insulin exerts pleiotropic effects on cell growth, survival, and metabolism, and its role in multiple tissues has been dissected using conditional knockout mice; however, its role in development has not been studied. Lineage tracing experiments have demonstrated that interscapular brown adipose tissue (BAT) arises from a Myf5-positive lineage shared with skeletal muscle and distinct from the majority of white adipose tissue (WAT) precursors. In this study, we sought to investigate the effects of impaired insulin signaling in the Myf5-expressing precursor cells by deleting the insulin receptor gene. Mice lacking insulin receptor in the Myf5 lineage (Myf5IRKO) have a decrease of interscapular BAT mass; however, muscle development appeared normal. Histologically, the residual BAT had decreased cell size but appeared mature and potentially functional. Expression of adipogenic inhibitors preadipocyte factor-1, Necdin, and wingless-type MMTV integration site member 10a in the residual BAT tissue was nonetheless increased compared with controls, and there was an enrichment of progenitor cells with impaired adipogenic differentiation capacity, suggesting a suppression of adipogenesis in BAT. Surprisingly, when cold challenged, Myf5IRKO mice did not show impaired thermogenesis. This resistance to cold could be attributed to an increased presence of uncoupling protein 1-positive brown adipocytes in sc WAT as well as increased expression of lipolytic activity in BAT. These data suggest a critical role of insulin signaling in the development of interscapular BAT from Myf5-positive progenitor cells, but it appears to be dispensable for muscle development. They also underscore the importance of compensatory browning of sc WAT in the absence of BAT for thermoregulation.

Indexed as

Adipose Tissue, BrownAdipose Tissue, WhiteAnimalsCalcium-Binding ProteinsGene Expression Regulation, DevelopmentalInsulinIntercellular Signaling Peptides and ProteinsIon ChannelsMiceMice, KnockoutMitochondrial ProteinsMuscle DevelopmentMuscle StrengthMyogenic Regulatory Factor 5Nerve Tissue ProteinsNuclear ProteinsCalcium-Binding ProteinsDlk1 protein, mouseInsulinIntercellular Signaling Peptides and ProteinsIon ChannelsMitochondrial ProteinsMyf5 protein, mouseMyogenic Regulatory Factor 5necdinNerve Tissue ProteinsNuclear ProteinsReceptor, InsulinRNA, MessengerUCP1 protein, humanUcp1 protein, mouseUncoupling Protein 1Wnt10a protein, mouseWnt Proteins

Identifiers

PMID25625589
PMCPMC4398768
OpenAlexW2108117282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.